Physician

Benjamin Huang, M.D.

According to 2025 Medicare claims, Benjamin Huang, M.D. (NPI: 1508122516) practices nephrology in the Crestview-Fort Walton Beach-Destin, FL market, with the plurality of this provider's patient population coming from Okaloosa, FL. This provider's primary affiliated billing organization is PENSACOLA NEPHROLOGY, PA (NPI: 1518969765; TIN: 59-3580766) and primary practice location at 32504-7152.

Huang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 952 traditional Medicare patients, billed 4,230 HCPCS/CPT codes, and received $432,456 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 1,018 prescription claims across 245 beneficiaries totaling $217,413 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). DME data shows 39 claims. Open Payments data shows 39 records totaling $1,276. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $16,336 to $432,456. Similarly, Part D prescription costs have risen steadily, from $115 to $217,413. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	87	167	$16,336
2020	359	705	$75,916
2021	635	2,581	$331,969
2022	821	3,569	$384,479
2023	913	3,817	$421,316
2024	952	4,230	$432,456

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	12	$115
2017	12	42	$12,647
2018	16	45	$8,087
2019	N/R	21	$587
2020	13	27	$4,878
2021	64	251	$30,600
2022	148	543	$105,279
2023	227	941	$234,845
2024	245	1,018	$217,413

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	13	$734
2016	N/R	11	$279
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	39	$738

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	158	168	$109
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	178	415	$100
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	385	765	$93
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	324	901	$66
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	379	679	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Velphoro	Sucroferric Oxyhydroxide	27	870	$70,092
Jardiance	Empagliflozin	35	2,140	$38,808
Farxiga	Dapagliflozin Propanediol	29	1,710	$31,139
Veltassa	Patiromer Calcium Sorbitex	18	874	$29,375
Auryxia	Ferric Citrate	11	330	$12,290

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	17	$393
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	11	$207
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	11	$138

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	39	$1,276	Outset Medical Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Benjamin Huang, M.D.?

Tedicare shows public-source Medicare data for Benjamin Huang, M.D. (NPI 1508122516), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Benjamin Huang, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Benjamin Huang, M.D.?

Benjamin Huang, M.D. is linked to PENSACOLA NEPHROLOGY, PA (billing NPI 1518969765) in the available physician profile data.

Does Benjamin Huang, M.D. have Open Payments data?

Benjamin Huang, M.D. has 39 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.